|
Name |
(1S,3S,4R,5S,8R,9S,10R,11R,14S,16R,18R)-5-benzyl-9,10-dihydroxy-3,12,14-trimethyl-2-methylidene-19-oxa-6-azapentacyclo[14.2.1.04,8.08,18.011,17]nonadec-12-en-7-one
|
| Molecular Formula | C28H35NO4 | |
| IUPAC Name* |
(1S,3S,4R,5S,8R,9S,10R,11R,14S,16R,18R)-5-benzyl-9,10-dihydroxy-3,12,14-trimethyl-2-methylidene-19-oxa-6-azapentacyclo[14.2.1.04,8.08,18.011,17]nonadec-12-en-7-one
|
|
| SMILES |
C[C@H]1C[C@@H]2C3[C@@H]([C@H]([C@H]([C@]45[C@@H]3[C@H](O2)C(=C)[C@H]([C@H]4[C@@H](NC5=O)CC6=CC=CC=C6)C)O)O)C(=C1)C
|
|
| InChI |
InChI=1S/C28H35NO4/c1-13-10-14(2)20-21-19(11-13)33-25-16(4)15(3)22-18(12-17-8-6-5-7-9-17)29-27(32)28(22,23(21)25)26(31)24(20)30/h5-10,13,15,18-26,30-31H,4,11-12H2,1-3H3,(H,29,32)/t13-,15-,18+,19-,20+,21?,22+,23+,24-,25-,26-,28-/m1/s1
|
|
| InChIKey |
MLMRFXVBCDFIAD-LTMHNWRYSA-N
|
|
| Synonyms |
Phomopchalasin B
|
|
| CAS | NA | |
| PubChem CID | 139591043 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 449.6 | ALogp: | 2.3 |
| HBD: | 3 | HBA: | 4 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 78.8 | Aromatic Rings: | 6 |
| Heavy Atoms: | 33 | QED Weighted: | 0.602 |
| Caco-2 Permeability: | -5.239 | MDCK Permeability: | 0.00004380 |
| Pgp-inhibitor: | 0.05 | Pgp-substrate: | 0.995 |
| Human Intestinal Absorption (HIA): | 0.057 | 20% Bioavailability (F20%): | 0.05 |
| 30% Bioavailability (F30%): | 0.805 |
| Blood-Brain-Barrier Penetration (BBB): | 0.113 | Plasma Protein Binding (PPB): | 86.93% |
| Volume Distribution (VD): | 1.531 | Fu: | 7.03% |
| CYP1A2-inhibitor: | 0.085 | CYP1A2-substrate: | 0.127 |
| CYP2C19-inhibitor: | 0.096 | CYP2C19-substrate: | 0.57 |
| CYP2C9-inhibitor: | 0.145 | CYP2C9-substrate: | 0.039 |
| CYP2D6-inhibitor: | 0.015 | CYP2D6-substrate: | 0.179 |
| CYP3A4-inhibitor: | 0.847 | CYP3A4-substrate: | 0.317 |
| Clearance (CL): | 10.443 | Half-life (T1/2): | 0.188 |
| hERG Blockers: | 0.423 | Human Hepatotoxicity (H-HT): | 0.769 |
| Drug-inuced Liver Injury (DILI): | 0.772 | AMES Toxicity: | 0.035 |
| Rat Oral Acute Toxicity: | 0.709 | Maximum Recommended Daily Dose: | 0.944 |
| Skin Sensitization: | 0.13 | Carcinogencity: | 0.091 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.009 |
| Respiratory Toxicity: | 0.974 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003956 | ![]() |
0.784 | D0SP3D | ![]() |
0.223 | ||
| ENC005128 | ![]() |
0.752 | D09NNH | ![]() |
0.222 | ||
| ENC006060 | ![]() |
0.696 | D0V3ZA | ![]() |
0.222 | ||
| ENC004543 | ![]() |
0.643 | D0R1BD | ![]() |
0.220 | ||
| ENC003937 | ![]() |
0.619 | D0IN7I | ![]() |
0.217 | ||
| ENC005127 | ![]() |
0.596 | D0M6VK | ![]() |
0.217 | ||
| ENC005759 | ![]() |
0.553 | D05ZJG | ![]() |
0.217 | ||
| ENC003955 | ![]() |
0.534 | D06CWH | ![]() |
0.217 | ||
| ENC006133 | ![]() |
0.521 | D08UMH | ![]() |
0.216 | ||
| ENC005760 | ![]() |
0.521 | D0I2VK | ![]() |
0.216 | ||